Brooke is an assistant editor for The American Journal of Managed Care® (AJMC®). She joined AJMC in 2023, where she produces written content covering multiple disease states.
She has a BA in journalism from Seton Hall University. You can connect with Brooke on LinkedIn.
Severe Influenza Strikes US Children and Adolescents in 2022-2023 Season
October 27th 2023The CDC found that the 2022-2023 influenza season had high severity among children and adolescents, resulting in them recommending that everyone receive the annual influenza vaccine by the end of October.
Read More
Dr Saira Jan Explains Oncology Therapeutics Home Infusion Pilot Program
October 27th 2023Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, provides an overview of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health, discussing the program's origin, objectives, and beyond.
Read More
Posters Presented at ACG 2023 Explore Pediatric Patient EoE Risk, Allergic Comorbidities Prevalence
October 26th 2023Posters presented at the American College of Gastroenterology's (ACG's) 2023 Annual Scientific Meeting examined potential environmental risks of eosinophilic esophagitis (EoE) on the pediatric population, as well as the presence of allergic comorbidities in children diagnosed with EoE.
Read More
Dr April Armstrong: Clinician Education Needed to Overcome AD Treatment Barriers
October 26th 2023April Armstrong, MD, MPH, of University of California, Los Angeles, gave an overview of her Fall Clinical Dermatology session on treating atopic dermatitis (AD) in patients with diverse skin tones and weighed in on how to address related treatment barriers.
Read More
Dr April Armstrong Identifies Main AD Health Care Gaps
October 24th 2023April Armstrong, MD, MPH, of University of California, Los Angeles, explained that the main health care gap within the atopic dermatitis (AD) realm is that many clinicians are not comfortable prescribing systemic medications.
Read More
Education Is the Biggest Factor in Promoting Biosimilar Use, Says Dr Prerakkumar Parikh
October 20th 2023Prerakkumar Parikh, PharmD, of Megallen Rx Management/Prime Therapeutics, detailed the impact of formulary placement of biosimilars on cost burden along with how stakeholders can work with pharmacy benefit managers to promote biosimilar use.
Read More
Dr Saira Jan Shares Oncology Therapeutics Home Infusion Program Findings
October 20th 2023Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, discussed the primary findings of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health, focusing on patient and provider experiences.
Read More
Dr Chelsee Jensen Comments on Recent Biosimilar Approvals, Patient Access
October 19th 2023Chelsee Jensen, PharmD, BCPS, of Mayo Clinic, commented on the recent FDA biosimilar approvals and what they mean for the industry's future, as well as how to ensure biosimilars are accessible to all patients.
Read More
Jeff McIntyre: How Managed Care Professionals Can Prevent Delayed NASH Diagnoses
October 18th 2023Jeff McIntyre, MA, of the Global Liver Institute, discussed how the delayed diagnosis of nonalcoholic steatohepatitis (NASH) affects patients and how health care and managed care professionals can help expedite diagnosis and treatment.
Read More
Gefapixant Made Modest Symptom Improvements in Patients With Chronic Cough, Review Says
October 12th 2023Based on the researchers’ findings, gefapixant provides small benefits in cough severity, cough frequency, and cough-specific quality of life in patients with refractory or unexplained chronic coughs.
Read More
Alcohol Use Not Associated With Lower Odds of Achieving SVR With Hepatitis C Treatment
October 4th 2023The researchers noted that their findings suggest clinicians and policy makers should encourage hepatitis C virus (HCV) treatment in those with unhealthy alcohol consumption or alcohol use disorder (AUD) rather than create barriers to it.
Read More
US Oncology Network’s Rhonda Henschel Discusses Value-Based Care, Payer Relations Initiatives
October 3rd 2023Rhonda Henschel, US Oncology Network's vice president of payer relations, summarized what she learned from the Minnesota Oncology IVBM and discussed new developments in the value-based cancer care space.
Read More